Bobby is the Managing Director of Orlando Health Ventures. This hospital-based strategic venture fund invests in companies disrupting the healthcare industry while aligning with the mission of Orlando Health. He brings more than 10 years of experience in the corporate venture capital space for healthcare organizations and was previously Managing Director for UNC Rex Health Ventures. Currently, Bobby also serves on the boards of Emergo Therapeutics, Vesalio and Bio 54. Bobby received his bachelor’s degree in finance from the University of Notre Dame and an International MBA from the Moore School of Business, University of South Carolina